Sefaxersen (RO7434656) — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-31 in 2mo
ESTIMATED |
READOUT
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Partici
Phase 3 · Primary IgA Nephropathy |
Hoffmann-La Roche | Sefaxersen (RO7434656) |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|